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Background and Purpose Although numerous measures for stroke exist, stroke remains one of the 
leading causes of death in Japan. In this study, we aimed to determine the long-term survival rate 
after first-ever stroke using data from a large-scale population-based stroke registry study in Japan. 
Methods Part of the Shiga Stroke and Heart Attack Registry, the Shiga Stroke Registry is an 
ongoing population-based registry study of stroke, which covers approximately 1.4 million residents 
of Shiga Prefecture in Japan. A total 1,880 patients with non-fatal first-ever stroke (among 29-day 
survivors after stroke onset) registered in 2011 were followed up until December 2016. Five-year 
cumulative survival rates were estimated using the Kaplan-Meier method, according to subtype of 
the index stroke. Cox proportional hazards models were used to assess predictors of subsequent all-
cause death.
Results During an average 4.3-year follow-up period, 677 patients died. The 5-year cumulative 
survival rate after non-fatal first-ever stroke was 65.9%. Heterogeneity was present in 5-year 
cumulative survival according to stroke subtype: lacunar infarction, 75.1%; large-artery infarction, 
61.5%; cardioembolic infarction, 44.9%; intracerebral hemorrhage, 69.1%; and subarachnoid 
hemorrhage, 77.9%. Age, male sex, Japan Coma Scale score on admission, and modified Rankin 
Scale score before stroke onset were associated with increased mortality during the chronic phase 
of ischemic and hemorrhagic stroke.
Conclusions In this study conducted in a real-world setting of Japan, the 5-year survival rate after 
non-fatal first-ever stroke remained low, particularly among patients with cardioembolic infarction 
and large-artery infarction in the present population-based stroke registry.
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Introduction
During the past five decades, age-standardized stroke mortality 
has decreased in Japan.1 However, in Japan, stroke is still one of 
the leading causes of death2 and disability.3 In all regions of the 
world, the age-adjusted stroke mortality rate has rapidly de-
creased whereas the incidence rate has less steep decreased in 
high-income Asian pacific or Southeast Asian countries or in-
creased in China.4 The rapid decrease in age-adjusted mortality 
rates and less steep decrease or increase in age-adjusted inci-
dence rates have led to an increased number of stroke survi-
vors.4 Using data from the Shiga Stroke registry study, we previ-
ously reported that case fatality rates were lower than those of 
previous studies from Japan and other countries,5 which might 
also suggest increase in number of stroke survivors during the 
past few decades. The excess risk of death has been reported to 
be highest during the acute phase but persists during the sever-
al years following stroke.6-8 However, there is limited evidence 
of long-term mortality among patients who experience non-fa-
tal stroke in Japan, which is the most aged society and the first 
nation to face a super-aging society in the world.9
As a part of the Shiga Stroke and Heart Attack Registry, the 
Shiga Stroke Registry is one of the largest ongoing population-
based registry study of stroke in Japan. We previously reported 
the incidence rate5 and both acute and 2-year survival rates10 
of stroke, using data from this study. We aimed to investigate 
the current cumulative and relative 5-year survival rates after 
non-fatal first-ever stroke, using a large-scale comprehensive 
population-based stroke registry in Shiga Prefecture, Japan. 
Methods
Study design
The design of the Shiga Stroke Registry has been described else-
where in detail.5,10 The Shiga Stroke Registry is a population-
based registry study designed to build a complete information 
system regarding acute ischemic and non-traumatic hemor-
rhagic stroke management in Shiga Prefecture, Japan. Shiga 
Prefecture is located in the central part of Honshu Island. Ac-
cording to the 2011 census, the population of Shiga Prefecture 
was 1,400,745 residents (689,859 men and 710,866 women).
Diagnosis of stroke was defined as a sudden onset of focal 
neurological deficits persisting for more than 24 hours, accord-
ing to the Monitoring Trends and Determinants in Cardiovascu-
lar Disease (WHO-MONICA) Project.11 A total 2,176 cases of 
first-ever stroke, with onset dates ranging from 1 January to 31 
December in 2011, were followed up until December 2016. A 
patient with non-fatal stroke was defined as a person who ex-
perienced stroke and was alive at 29 days after onset of the in-
dex stroke. We excluded 296 patients with fatal stroke who 
died within 28 days. A total 1,880 patients with non-fatal first-
ever stroke were included in the present analysis. A sensitivity 
analysis using 2,176 fatal/non-fatal first-ever stroke patients 
was also conducted. The present study was approved by the In-
stitutional Review Board of Shiga University of Medical Science.
Written informed consent by the patients was waived due to a 
retrospective nature of our study.
Definition of index stroke and its subtypes
Stroke was classified as ischemic or hemorrhagic stroke. Isch-
emic stroke was further divided into four clinical categories: 
lacunar infarction, large-artery infarction, cardioembolic in-
farction, or undetermined type, based on the criteria for the 
type of stroke of the Trial of ORG 10172 in Acute Stroke Treat-
ment (TOAST) study.12 Hemorrhagic stroke was further divided 
into two clinical categories: intracerebral hemorrhage and 
subarachnoid hemorrhage.
Clinical features and medical histories
Information on clinical features, including transient ischemic 
attack (TIA), atrial fibrillation, myocardial infarction, hyperten-
sion medication, diabetes, dyslipidemia, modified Rankin Scale 
(mRS) score13 before onset, and smoking and drinking status at 
baseline, was obtained from the medical records of all patients 
with stroke. Atrial fibrillation was defined as a history of atrial 
fibrillation and/or a clinical diagnosis based on electrocardio-
gram (ECG) and/or ECG monitoring during hospitalization. The 
Japan Coma Scale (JCS)14 score is a 10-grade scale that is 
widely used in Japan to assess consciousness (JCS 0, alert; JCS 
1–3, possible eye-opening, not lucid; JCS 10–30, possible eye-
opening upon stimulation; JCS 100–300, no eye-opening, 
coma) (Supplementary Table 1). Hypertension medication was 
defined as the use of antihypertensive medication before onset 
of the index stroke. Diabetes was defined as casual blood glu-
cose ≥11.1 mmol/L, use of antidiabetic medication, and/or a 
history of diabetes. Dyslipidemia was defined as total choles-
terol ≥5.69 mmol/L, low density lipoprotein cholesterol ≥4.14 
mmol/L, taking medication for dyslipidemia, and/or a history of 
dyslipidemia. Smoking and drinking habits were categorized as 
none, past, and current. 
Follow-up survey and outcome
All patients with first-ever stroke were followed up until De-
cember 2016, using death certificate information. Information 
from the death certificates of all deceased individuals was col-
lected, with the permission of the Japanese Ministry of Health, 
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Labor and Welfare, and matched with all stroke cases. The 
main outcome of this study was all-cause death.
Statistical analysis
Cumulative survival rates of first-ever stroke cases at 5 years 
were estimated using Kaplan-Meier methods. Log-rank tests were 
used to compare survival rates across subtypes of stroke and isch-
emic stroke. Relative survival rate was defined as the ratio of ob-
servation survival rate during the follow-up period to the expect-
ed survival rate in the population matched by age, sex, and calen-
dar year of the observational group. The expected survival rate 
was calculated using the Ederer I method15 and Japanese cohort 
survival tables.16 In addition, excess mortality risk was calculated, 
to compare the cumulative mortality rate with the expected mo-
Table 1. Characteristics of non-fatal first-ever stroke patients survived 







Total no. 1,296 583 1,880
Men 743 (57.3) 260 (44.6) 1,003 (53.4)
Age (yr) 74.1±13.2 68.2±15.1 72.3±14.1
Past history
Transient ischemic attacks
Yes 71 (5.5) 8 (1.4) 79 (4.2)
No 1,222 (94.3) 572 (98.1) 1,795 (95.5)
Unknown 3 (0.2) 3 (0.5) 6 (0.3)
Atrial fibrillation
Yes 286 (22.1) 38 (6.5) 324 (17.2)
No 1,004 (77.5) 540 (92.6) 1,545 (82.2)
Unknown 6 (0.5) 5 (0.9) 11 (0.6)
Myocardial infarction
Yes 79 (6.1) 27 (4.6) 107 (5.7)
No 1,215 (93.8) 554 (95) 1,769 (94.1)
Unknown 2 (0.2) 2 (0.3) 4 (0.2)
Hypertension medication
Yes 656 (50.6) 224 (38.4) 880 (46.8)
No 635 (49) 355 (60.9) 991 (52.7)
Unknown 5 (0.4) 4 (0.7) 9 (0.5)
Diabetes
Yes 360 (27.8) 114 (19.6) 474 (25.2)
No 930 (71.8) 466 (79.9) 1,397 (74.3)
Unknown 6 (0.5) 3 (0.5) 9 (0.5)
Dyslipidemia
Yes 510 (39.4) 158 (27.1) 668 (35.5)
No 748 (57.7) 377 (64.7) 1,126 (59.9)
Unknown 38 (2.9) 48 (8.2) 86 (4.6)
Modified Rankin Scale be-
fore on set
0 907 (70.0) 450 (77.2) 1,358 (72.2)
1 133 (10.3) 48 (8.2) 181 (9.6)
2 57 (4.4) 35 (6.0) 92 (4.9)
3 86 (6.6) 17 (2.9) 103 (5.5)
4 81 (6.3) 17 (2.9) 98 (5.2)
5 26 (2.0) 3 (0.5) 29 (1.5)
Unknown 6 (0.5) 13 (2.2) 19 (1.0)
Japan Coma Scale on ad-
mission
0 810 (62.5) 206 (35.3) 1,017 (54.1)
1 114 (8.8) 70 (12) 184 (9.8)
2 77 (5.9) 32 (5.5) 109 (5.8)
3 122 (9.4) 55 (9.4)  177 (9.4)







20 22 (1.7) 18 (3.1) 40 (2.1)
30 20 (1.5) 14 (2.4) 34 (1.8)
100 18 (1.4) 22 (3.8) 40 (2.1)
200 35 (2.7) 45 (7.7) 80 (4.3)
300 11 (0.8) 17 (2.9) 28 (1.5)
Unknown 3 (0.2) 2 (0.3) 5 (0.3)
Smoking
Nonsmoker 734 (56.6) 352 (60.4) 1,087 (57.8)
Past smoker 152 (11.7) 57 (9.8) 209 (11.1)
Current smoker 309 (23.8) 129 (22.1) 438 (23.3)
Unknown 101 (7.8) 45 (7.7) 146 (7.8)
Drinking
Nondrinker 642 (49.5) 296 (50.8) 938 (49.9)
Past drinker 21 (1.6) 7 (1.2) 28 (1.5)
Current drinker 468 (36.1) 213 (36.5) 682 (36.3)
Unknown 165 (12.7) 67 (11.5) 232 (12.3)
Index stroke subtype
Ischemic stroke 1,296 (100.0) 1,296 (68.9)
Lacunar infarction 346 (26.7) 346 (18.4)
Large artery infarction 413 (31.9) 413 (22.0)
Cardioembolic infarction 305 (23.5) 305 (16.2)
Ischemic stroke with oth-
er determined etiology
38 (2.9) 38 (2.0)
Ischemic stroke with un-
determined etiology
194 (15.0) 194 (10.3)
Intracerebral hemorrhage 447 (76.7) 447 (23.8)
Subarachnoid hemorrhage 136 (23.3) 136 (7.2)
Stroke, not specified as 
hemorrhage or infarction
1 (0.1)
Values are presented as number (%) or mean±standard deviation.
Table 1. Continued
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Table 2. Cumulative 5-year survival rate after non-fatal first-ever stroke by types of stroke and gender in the Shiga Stroke Registry
Variable
















Total stroke 319/1,003 68.2 66.7–69.7 322/877 63.3 61.7–64.9 641/1,880 65.9 64.8–67.0
Ischemic stroke 247/743 66.8 65.0–68.5 226/553 59.1 57.0–61.2 473/1,296 63.5 62.2–64.8
Lacunar infarction 50/208 76.0 73.0–78.9 36/138 73.9 70.2–77.7 86/346 75.1 72.8–77.5
Large artery infarction 91/252 63.9 60.9–66.9 68/161 57.8 53.9–61.7 159/413 61.5 59.1–63.9
Cardioembolic infarction 79/152 48.0 44.0–52.1 89/153 41.8 37.8–45.8 168/305 44.9 42.1–47.8
Other/undetermined* 27/131 79.4 75.9–82.9 33/101 67.3 62.7–72.0 60/232 74.1 71.3–77.0
Hemorrhagic stroke 72/260 72.3 69.5–75.1 96/323 70.3 67.7–72.8 168/583 71.2 69.3–73.1
Intracerebral hemorrhage 64/221 71.0 68.0–74.1 74/226 67.3 64.1–70.4 138/447 69.1 66.9–71.3
Subarachnoid hemorrhage 8/39 79.5 73.0–86.0 22/97 77.3 73.1–81.6 30/136 77.9 74.4–81.5
CI, confidence interval.
*Ischemic stroke with other determined etiology or ischemic stroke with undetermined etiology.
Men by stroke subtypes Men by ischemic stroke subtypes
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Figure 1. Five-year survival rate curve after non-fatal first-ever stroke for men by stroke subtypes (A), for men by ischemic stroke subtypes (B), for women by 
stroke types (C), and for women by ischemic stroke subtypes (D). P-values were calculated by log-rank test across subtypes of stroke (ischemic stroke, intracerebral 





Takashima et al.  Long-Term Survival Rate of Stroke in Japanese Population 
https://doi.org/10.5853/jos.2020.00325340 http://j-stroke.org
rality rate in the general population using Japanese cohort sur-
vival tables.16 A Cox proportional hazards model was used to 
evaluate possible predictors for subsequent death. Cases with 
missing data on TIA or atrial fibrillation (n=17), or a stroke case, 
not specified as hemorrhage or infarction (n=1) were excluded 
from the Cox proportional hazards analysis. A P-value less than 
0.05 was considered statistically significant. All analyses were 
performed using SAS version 9.4 (SAS Institute, Cary, NC, USA).
Results
The baseline characteristics of patients after non-fatal first-ev-
er stroke are shown according to type of index stroke (Table 1). 
A total of 1,880 cases of first-ever non-fatal stroke were as-
certained in 2011. The mean patient age was 74.1 years for 
ischemic stroke and 68.2 years for hemorrhagic stroke. The fre-
quencies of male sex, atrial fibrillation, moderate to severe dis-
ability before stroke onset (mRS 3 to 5), and coma (JCS score 
100 to 300) on admission were 53.4%, 17.2%, 12.2%, and 
7.9%, respectively. 
During an average 4.3-year follow-up period, 677 patients 
died (641 patients died within the 5 years). Table 2 shows the 
cumulative survival rates after non-fatal first-ever stroke and 
its subtypes. Among survivors of first-ever stroke, the 5-year 
cumulative survival rate was 65.9%. The 5-year cumulative 
survival rates were 63.5% for ischemic stroke, 69.1% for intra-
cerebral hemorrhage, and 77.9% for subarachnoid hemorrhage. 
Cumulative survival curves of non-fatal first-ever stroke and 
ischemic stroke subtypes were plotted separately for men and 
women (Figure 1).
Table 3. Relative survival rate after non-fatal first-ever stroke by types of stroke and gender in the Shiga Stroke Registry
Variable
Men Women Men and women
Survival rate (%) 95% CI Survival rate (%) 95% CI Survival rate (%) 95% CI
Total stroke 83.2 79.7–86.7 80.6 76.5–84.6 82.0 79.4–84.7
Ischemic stroke 83.3 79.0–87.5 79.1 73.7–84.6 81.6 78.2–84.9
Lacunar infarction 92.1 85.1–99.2 93.3 84.0–100.0 92.6 87.0–98.2
Large artery infarction 79.8 72.4–87.2 77.9 67.7–88.1 79.1 73.1–85.1
Cardioembolic infarction 65.5 54.7–76.4 62.3 50.7–73.8 64.0 56.1–71.9
Other/undetermined* 93.7 85.5–100.0 83.2 71.9–94.6 89.3 82.5–96.0
Hemorrhagic stroke 83.1 76.9–89.3 82.7 76.8–88.6 82.9 78.6–87.1
Intracerebral hemorrhage 82.7 75.8–89.6 81.9 74.5–89.4 82.3 77.2–87.4
Subarachnoid hemorrhage 85.2 71.6–98.8 84.2 75.1–93.3 84.5 76.9–92.1
Relative survival rates were calculated the ratio of observational survival rates to the expected survival rates in the age, sex, and calendar year matched gen-
eral Japanese population. The expected survival rate were calculated by Ederer I methods.15
CI, confidence interval.
*Ischemic stroke with other determined etiology or ischemic stroke with undetermined etiology.
Table 4. Cumulative 5-year survival rate after both nonfatal and fatal first-ever stroke by types of stroke and gender in the Shiga Stroke Registry
Variable
















Total stroke 454/1,138 60.1 58.7–61.6 483/1,038 53.5 51.9–55.0 937/2,176 56.9 55.9–58.0
Ischemic stroke 287/783 63.4 61.6–65.1 288/615 53.2 51.2–55.2 575/1,398 58.9 57.6–60.2
Lacunar infarction 50/208 76.0 73.0–78.9 42/144 70.8 67.0–74.6 92/352 73.9 71.5–76.2
Large artery infarction 101/262 61.5 58.4–64.5 84/177 52.5 48.8–56.3 185/439 57.9 55.5–60.2
Cardioembolic infarction 97/170 42.9 39.1–46.7 120/184 34.8 31.3–38.3 217/354 38.7 36.1–41.3
Other/undetermined* 39/143 72.7 69.0–76.5 42/110 61.8 57.2–66.5 81/253 68.0 65.1–70.9
Hemorrhagic stroke 153/341 55.1 52.4–57.8 184/411 55.2 52.8–57.7 337/752 55.2 53.4–57.0
Intracerebral hemorrhage 123/280 56.1 53.1–59.0 119/271 56.1 53.1–59.1 242/551 56.1 54.0–58.2
Subarachnoid hemorrhage 30/61 50.8 44.4–57.2 65/140 53.6 49.4–57.8 95/201 52.7 49.2–56.3
CI, confidence interval.
*Ischemic stroke with other determined etiology or ischemic stroke with undetermined etiology.
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Table 5. Multivariable analysis of prognostic predictors for fatality after non-fatal first-ever stroke
Variable
Hemorrhagic stroke Ischemic stroke
HR 95% CI P HR 95% CI P
Age (yr)
<45 Reference Reference
45–64 6.08 0.75–49.45 0.092 3.86 0.60–24.69 0.153
65–74 12.13 1.49–98.98 0.020 7.54 1.21–46.79 0.030
75–84 29.18 3.69–230.51 0.001 15.67 2.53–96.86 0.003
≥85 57.69 7.04–472.40 <0.001 37.03 5.96–230.24 <0.001
Women (vs. men) 0.48 0.32–0.72 <0.001 0.59 0.47–0.74 <0.001
JCS
0 Reference Reference
1 1.77 0.97–3.23 0.063 1.90 1.43–2.52 <0.001
2 2.65 1.37–5.12 0.004 1.65 1.17–2.33 0.005
3 2.15 1.23–3.75 0.007 1.72 1.26–2.35 0.001
10 1.88 1.12–3.16 0.017 2.54 1.74–3.70 <0.001
20 4.04 1.56–10.44 0.004 2.90 1.74–4.85 <0.001
30 2.99 1.26–7.12 0.013 3.35 1.63–6.89 0.001
100 2.16 0.87–5.36 0.097 3.95 2.26–6.91 <0.001
200 5.26 2.86–9.67 <0.001 5.74 3.51–9.40 <0.001
300 10.50 5.17–21.33 <0.001 3.36 1.60–7.06 0.001
Unknown 11.94 0.89–159.70 0.061 6.30 3.34–11.90 <0.001
History of TIA (vs. no)
Yes 0.97 0.33–2.86 0.952 0.88 0.59–1.32 0.534
Hypertension medication (vs. no)
Yes 0.91 0.65–1.26 0.570 0.94 0.78–1.14 0.539
Unknown 0.65 0.10–4.27 0.652 5.78 1.22–27.43 0.027
Diabetes (vs. no)
Yes 1.33 0.90–1.98 0.151 1.22 0.98–1.50 0.070
Unknown 1.18 0.42–3.34 0.751 0.56 0.13–2.41 0.436
Dyslipidemia (vs. no)
Yes 0.85 0.58–1.24 0.388 0.79 0.65–0.97 0.022
Unknown 1.11 0.61–2.00 0.739 1.10 0.73–1.67 0.643
Atrial fibrillation (vs. no)
Yes 1.58 0.95–2.61 0.078 1.40 1.14–1.73 0.002
Myocardial infarction (vs. no)
Yes 1.43 0.71–2.89 0.315 0.93 0.66–1.31 0.664
Unknown - – – – – -
Smoking (vs. nonsmoker)
Past smoker 0.59 0.31–1.12 0.107 1.23 0.90–1.67 0.196
Current smoker 1.27 0.81–2.01 0.302 1.07 0.81–1.42 0.619
Unknown 0.87 0.38–1.97 0.730 0.66 0.43–1.03 0.066
Drinker (vs. nondrinker)
Past drinker 3.09 1.23–7.76 0.016 0.74 0.26–2.09 0.569
Current drinker 0.68 0.46–1.02 0.064 0.80 0.63–1.02 0.072
Unknown 1.37 0.65–2.86 0.411 1.25 0.90–1.72 0.179
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Table 3 shows the relative survival rates of non-fatal first-ever 
stroke and its subtypes. The 5-year relative survival rate after 
non-fatal first-ever stroke was 82.0%. The 5-year relative sur-
vival rates were 81.6% for ischemic stroke (lacunar infarction, 
92.6%; large-artery infarction, 79.1%; and cardioembolic infarc-
tion, 64.0%), 82.3% for intracerebral hemorrhage, and 84.5% for 
subarachnoid hemorrhage. The 5-year excess mortality risk after 
non-fatal stroke was 1.75-fold higher than that among the gen-
eral Japanese population. Excess mortality risks were 1.66 for 
ischemic stroke (lacunar infarction, 1.32; large-artery infarction, 
1.75; and cardioembolic infarction, 1.88), 1.93 for intracerebral 
hemorrhage, and 2.84 for subarachnoid hemorrhage.
As for sensitivity analysis, the 5-year cumulative survival 
rates after both fatal and non-fatal first-ever stroke are shown 
in Table 4. Approximately 30% (296 out of 937) of fatal cases 
were observed during the first 28 days after stroke onset. The 
5-year cumulative survival rate after first-ever stroke was 
56.9%. Five-year cumulative survival rates were 58.9% for 
ischemic stroke, 56.1% for intracerebral hemorrhage, and 
52.7% for subarachnoid hemorrhage. The 5-year relative sur-
vival rates after both fatal and non-fatal first-ever stroke were 
76.6% for ischemic stroke, 68.6% for intracerebral hemor-
rhage, and 58.7% for subarachnoid hemorrhage.
Results of multivariable analysis for predictors of death after 
non-fatal first-ever stroke are shown in Table 5. Age, male sex, 
higher JCS score, atrial fibrillation, and disability before stroke 
onset were associated with a higher risk of subsequent death af-
ter non-fatal first-ever ischemic stroke; dyslipidemia was associ-
ated with a lower risk of future death. In non-fatal first-ever 
hemorrhagic stroke, age, male sex, JCS score, past drinker, and 
disability before onset were associated with subsequent death.
Discussion
In the present study using data of a large-scale, recent com-
prehensive population-based stroke registry, we demonstrated 
the current status of 5-year prognosis after first-ever stroke in 
a real-world setting of Japan. The 5-year cumulative survival 
rate after non-fatal first-ever stroke was 65.9%. Lower 5-year 
cumulative survival rates were observed for cardioembolic in-
farction (44.9%) and large-artery infarction (61.5%). The rela-
tive 5-year survival rate after non-fatal first-ever stroke was 
82.0%, and lower relative survival rates were observed for car-
dioembolic infarction (64.0%) and large-artery infarction 
(79.1%). Older age, male sex, higher JCS score on admission, 
and higher mRS score before stroke onset were associated with 
higher risk of subsequent death in both non-fatal first-ever 
ischemic and hemorrhagic stroke.
Five-year cumulative survival rates have been reported to be 
50% to 70% after total stroke6-8,17,18 and 30% to 40% after in-
tracerebral hemorrhage19-21 in studies conducted during the 
1980s, 1990s, and early 2000s. In the present study conducted 
during the 2010s in Japan, whose participants were slightly 
older than those of many previous studies, we demonstrated 
similar 5-year survival rates in a sensitivity analysis using 2,176 
fatal/no-fatal first-ever stroke patients. These findings suggest 
possible improvement in age-standardized 5-year survival rates 
during the past few decades, which might be derived from im-
provement in stroke care, advances in medical technology, and/
or reduction of stroke severity owing to improved management 
of cardiovascular risk factors, such as hypertension.
Cumulative survival rates might not be a useful indicator for 
older patients whose risk of death is very high. In our study, 
therefore, we also used the relative survival rate, which is an 
established method in population-based cancer epidemiology22 
for examining long-term survival. Relative survival rate is a 
Variable
Hemorrhagic stroke Ischemic stroke
HR 95% CI P HR 95% CI P
mRS before onset
0 Reference Reference
1 1.42 0.89–2.27 0.143 1.19 0.89–1.60 0.243
2 1.62 0.90–2.91 0.108 1.91 1.32–2.76 <0.001
3 1.45 0.71–2.98 0.311 1.53 1.09–2.15 0.014
4 1.07 0.51–2.23 0.863 2.37 1.71–3.29 <0.001
5 9.52 3.35–27.07 <0.001 2.88 1.67–4.97 <0.001
Unknown 3.81 2.01–7.23 <0.001 2.24 0.78–6.44 0.136
HR, hazard ration; CI, confidence interval; JCS, Japan Coma Scale (JCS 0, alert; JCS 1–3, possible eye-opening, not lucid; JCS 10–30, possible eye-opening 
upon stimulation; JCS 100–300, no eye-opening and coma); TIA, transient ischemic attack; mRS, modified Rankin Scale.
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method to evaluate a corrected survival rate without cause of 
death information. To our knowledge, this is the first report to 
calculate recent relative survival rates after non-fatal stroke 
over the 5-year study period. We also estimated the excess 
mortality risk after non-fatal stroke over the 5-year study peri-
od to be approximately 1.8-fold. These findings are consistent 
with prior studies reporting the excess mortality risk after non-
fatal stroke for more than 5 years as 1.9- to 2.9-fold greater.6-8
In this study, older age, male sex, severity of index stroke, 
and disability (mRS) before onset of the index stroke increased 
the risk of future death after non-fatal first-ever stroke. These 
findings are consistent with prior review articles of intracere-
bral hemorrhage, which reported old age and severity of the 
index stroke as predictors for long term fatality,20,23 as well as 
epidemiological studies reporting that the pre-stroke Barthel 
Index was associated with subsequent death after non-fatal 
first-ever stroke.6 Cumulative and relative survival rates in men 
were better than these in women. The discrepancy might be 
due to that mean age of stroke onset in women was 6 years 
older than that in men (75 years vs. 69 years). We previously 
reported that high JCS scores on admission predicted fatality 
at more than 2 years after stroke10 as well as short-term 
death.24,25 In this study, we confirmed these prior findings and 
demonstrated that the association between high JCS scores on 
admission and high case fatality persists for more than 5 years 
after first-ever non-fatal ischemic and hemorrhagic stroke. 
To our knowledge, this is the first study to report the current 
status of 5-year prognosis for type-specific stroke based on a 
large-scale, comprehensive, population-based registry in Asia. 
This study also has several limitations. First, owing to a lack of 
information about the causes of death, we could not examine 
cause-specific survival rates. Second, we only used information 
obtained from death certificates for residents of Shiga Prefec-
ture. Patients with stroke who relocated after stroke onset 
were lost to follow-up. Therefore, the survival rates after stroke 
onset might have been overestimated. However, according to 
reports on internal migration derived from the Basic Resident 
Registers, 5.1% of residents moved out of Shiga Prefecture 
during the 5-year study period. 
Conclusions
In the present study using data of a large-scale comprehensive 
population-based stroke registry in a real-world setting of Ja-
pan, resent 5-year survival after non-fatal first-ever stroke re-
mained low, particularly after cardioembolic infarction and 
large-artery infarction. These findings reemphasize the impor-
tance of secondary stroke prevention in Japan.
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3 Does not recall name and birthday
10 Opens eyes in response to normal voice
20 Opens eyes in response to loud voice or shaking body
30 Opens eyes in response to painful stimuli with repeated call
100 Does not open eyes but respond with movements to avoid painful stimuli
200 Does not open eyes but respond with slight movements to avoid painful stimuli (including decerebrate and decorticate response)
300 Does not open eyes and make any movements in response to painful stimuli
JCS, Japan Coma Scale.
